Vnitr Lek 2005, 51(1):119-122

Komentář k Doporučení American Heart Association/American College of Cardiology Foundation pro léčbu warfarinem

M. Penka
Oddělení klinické hematologie FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Miroslav Penka, CSc.

Received: July 30, 2004; Published: January 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Penka M. Komentář k Doporučení American Heart Association/American College of Cardiology Foundation pro léčbu warfarinem. Vnitr Lek. 2005;51(1):119-122.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ansell J, Hirsh J, Dalen J et al. Managing oral anticoagulant therapy. Chest 2001; 119: 22S-38S. Go to original source... Go to PubMed...
    2. British Committee for Standards in Haematology: Guidelines on Oral Anticoagulation: 3rd Edition. Brit J Haematol 1998; 101: 374-387. Go to original source... Go to PubMed...
    3. Chai SJ, Macik BG. Improving the Safety Profile of Warfarin. Sem Hematol 2002; 3(39): 179-186. Go to original source... Go to PubMed...
    4. Gumulec J, Penka M, Radina M. Profylaxe hluboké žilní trombózy a plicní embolizace. Antiokoagulační léčba 2.0. CD Program. Praha: Orion Pharma 2003.
    5. DeLoughery TG. Anticoagulant therapy in special circumstances. Curr Cardiol Rep 2000; 2: 74-77. Go to original source... Go to PubMed...
    6. Geerts WH, Heit JA, Clagett GP et al. Prevention of Venous Thrombembolism. Chest 2001; 119: 132S-175S. Go to original source... Go to PubMed...
    7. Ginsberg, JS, Greer I, Hirsh J. Use of Antithrombotick Agents During Pregnancy. Chest 2001; 119: 122S-131S. Go to original source... Go to PubMed...
    8. Hirsh J, Dalen JE, Anderson DR et al. Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range. Chest 2001; 119: 8S-21S. Go to original source... Go to PubMed...
    9. Hyers TM, Agnelli G, Hull RD et al. Antihtrombotic Therapy for Venous Thromboembolic Disease. Chest 2001; 119: 176S-193S. Go to original source... Go to PubMed...
    10. Kessler P. Léčba orálními antikoagulancii. Praha: Orion 2002: 1-62.
    11. Levine MN, Raskob G, Landefeld S et al. Hemorrhagic Complications of Anticoagulant Treatment. Chest 2001; 119: 108S-121S. Go to original source... Go to PubMed...
    12. Matýšková M, Penka M Interakce antikoagulačních léků s potravinami a potravinovými doplňky. Interní medicina pro praxi 2000; 5: 29-33.
    13. Penka M, Matýšková M, Buliková A et al. Příprava nemocného s dlouhodobou antikoagulační léčbou v ambulantní praxi k chirurgickému výkonu. Interní medicina pro praxi 2000; 5: 20-23.
    14. Penka M. Perorální antikoagulační léčba a její ovlivnění dietou a souběžně podávanými léky. Medinews 2003; 4: 218-221.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.